By creating fertility reserves, women are now able to become pregnant using their own eggs, even after menopause. Multiple arguments already exist against postmenopausal motherhood, most of which stress the potential risk of damage involved due to the mother's advanced age. Consequently, the question arises: Can successful antiaging medicine be applied to preserve or enhance cognitive and physical capacity at an advanced age and invalidate these objections? In this article, we shall explore this issue further and come to three main conclusions: (1) Until now, enabling postmenopausal women to become pregnant has not been a specific objective of antiaging medicine. (2) Postmenopausal motherhood can find legitimacy through the development and success of antiaging medicine. (3) The acceptance of postmenopausal motherhoods in our society first requires that antiaging medicine itself find some sort of ethical legitimacy. To evaluate the arguments for and against antiaging medicine and postmenopausal motherhood, it is important to take into consideration two points more in depth, which are constantly being impacted by both medical arguments alike: (1) The identity and role of medicine itself as well as (2) the normative role of our body`s natural boundaries.
PaulsonRJ, SauerMV. Pregnancies in post-menopausal women. Hum Reprod, 1994; 9:571–572.
3.
YokotaY, SatoS, YokotaM, YokotaH, ArakiY. Birth of a healthy baby following vitrification of human blastocysts. Fertil Steril, 2001; 75:1027–1029.
4.
FlamigniC. Egg donation to women over 40 years of age. Hum Reprod, 1993; 8,9:1343–1344.
5.
HarwoodK. Egg freezing: A breakthrough for reproductive autonomy?Bioethics, 2009; 23:39–46.
6.
JainJK, FrancisMM, MarshEM, McGonnellG, QuinnP, ChungK, PaulsonRJ. Oocyte cryopreservation: A promising strategy for circumventing the age-related decline in human fertility. Fertil Steril, 2006; 85,Suppl 2:S7.
FriesJF. Aging, natural death, and the compression of morbidity. N Engl J Med, 1980; 303:130–135.
9.
PostSG, BinstockRH. The fountain of youth. Oxford University Press: Oxford, 2004.
10.
JuengstET. Anti-aging interventions: ethical and social issues. PostSG. Encyclopedia of Bioethics, 3rd. Gale Cengage Learning: New York, 2003; 112–116.
11.
de GreyADNJ, RaeM. Ending aging: The rejuvenation breakthroughs that could reverse human aging in our lifetime. St. Martin's Press: New York, 2007.
12.
de GreyADNJ. Compression of morbidity: The hype and the reality. Rejuvenation Res, 2006; 9:1–2.
13.
KlatzR, GoldmanR. The official anti-aging revolution: Stop the clock: Time is on your side for a younger, stronger, happier You. Basic Health Publications: Laguna Beach, 2007.
14.
GiampapaV, RonaldP, ZimmermanM. The anti-aging solution: 5 simple steps to looking and feeling young. John Wiley & Sons: Hoboken, 2004.
15.
KlatzRM. The Benefits of Immortality. Futurist, 2002; 1–2:49–51.
16.
PartridgeB, HallW. The search for Methuselah. Should we endeavour to increase the maximum human lifespan?EMBO Rep, 2007; 8:888–891.
17.
MackeyT. An ethical assessment of anti-aging medicine. J Anti-Aging Med, 2003; 6:187–204.
18.
MoodyHR. Who's afraid of life extension?Generations, 2001; 25:33–37.
19.
StuckelbergerA, WannerP. Anti-Ageing Medicine: Myths and Chances. VDF: Zurich, 2008.
20.
KlatzR. New Horizons for the clinical specialty of anti aging medicine. Ann NY Acad Sci, 2005; 1057:536–544.
21.
KerosV, XellaS, HultenbyK, PetterssonK, SheikhiM, VolpeA, HreinssonJ, HovattaO. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod, 2009; 24:1670–1683.
22.
MukaidaT, NakamuraS, TomiyamaT, WadaS, OkaC, KasaiM, TakahashiK. Vitrification of human blastocysts using cryoloops: Clinical outcome of 223 cycles. Hum Reprod, 2003; 18:384–391.
23.
KuleshovaL, GianaroliL, MagliC, FerrarettiA, TrounsonA. Birth following vitrification of a small number of human oocytes. Hum Reprod, 1999; 14:3077–3079.
24.
NoyesN, KnopmanJ, LabellaP, McCaffreyC, Clark-WilliamsM, GrifoJ. Oocyte cryopreservation outcomes including pre-cryopreservation and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes. Fertil Steril, 2010Feb24[Epub ahead of print]LoutradiKE, KolibianakisEM, VenetisCA, PapanikolaouEG, PadosG, BontisI, TarlatzisBC. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril, 2008; 90:186–193.
25.
CohenJ, IngeKL, WikerSR, WrightG, FehillyCB, TurnerTG. Duration of storage of cryopreserved human embryos. J Vitro Fertilisation Embryo Transf, 1998; 5:301–303.
26.
KellySM, RaoD, DeanNL, TanSL. In vitro fertilisation and embryo banking. TulandiT, GosdenRG. Preservation of Fertility: Taylor & Francis London, 2000; 101–110.
27.
IonescuC. When this new baby is 16, her mother will be 82. www.timesonline.co.uk/tol/news/world/article413433.ece/.
28.
HeffnerLJ. Advanced maternal age—how old is too old?N Engl J Med, 2004; 351:1927–1929.
29.
PowellK. Age is no barrier. Nature, 2004; 432:40–42.
30.
AntinoriS, VersaciC, Hossein GholamiG, CaffaB, PanciC. A child is a joy at any age. Hum Reprod, 1993; 8:1542.
31.
EdwardsRG. Pregnancies are acceptable in post-menopausal women. Hum Reprod, 1993; 8:1542–1544.
32.
BairdP. IVF for postmenopausal women. Can Med Assoc J, 1996; 155,7:860.
33.
SmajdorA. The ethics of egg donation in the over fifties. Menopause, 2008; 14:173–177.
34.
OktayK. Fertility preservation: an emerging discipline in the care of young patients with cancer. Lancet, 2005; 6:192–193.
35.
JerussJS, WoodruffTK. Preservation of fertility in patients with cancer. New Engl J Med, 2009; 360:902–911.
36.
LoboRA. Potential options for preservation of fertility in women. New Engl J Med, 2009; 353:64–73.
37.
ChibberR. Child-bearing beyond age 50: pregnancy outcome in 59 cases “a concern?”Arch Gynecol Obstet, 2005; 271:189–194.
38.
StrongC. Ethics in reproductive and perinatal medicine: A new framework. Yale University Press: New Haven, 1997.
39.
PaulsonRJ, BoostanfarR, SaadatP, MorE, TourgemanDE, SlaterCC, FrancisMM, JainJK. Pregnancy in the sixth decade of life: Obstetrics outcomes in women of advanced reproductive age. JAMA, 2002; 288:2320–2323.
40.
SalihuHM, ShumoertMN, SlayM, KirbyRS, AlexanderGR. Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol, 2003; 102:1006–1014.
41.
TowerC. Pregnancy in peri- and postmenopausal women: Challenges in management. Menopause, 2009; 15:165–168.
42.
RoizenM. RealAge: Are you as young as you can be?Cliff Street Books: New York, 1999. www.realage.com/.
43.
BenshushanA, SchenkerJG. Age limitation in human reproduction: Is it justified?J Assist Reprod Gen, 1993; 10:321–331.
44.
CutasD. Postmenopausal motherhood: Immoral, illegal? A case study. Bioethics, 2007; 21:458–463.
45.
MoriT. Pregnancies in post-menopausal women: Post-menopausal pregnancy is permissible for women below 60 years of age. Hum Reprod, 1994; 9:187.
46.
KlugeE-H. Reproductive technology and postmenopausal motherhood. Can Med Assoc J, 1994; 151:353–355.
47.
PetersenJL. Global implications of extending the life span. J Anti-Aging Med, 1998; 1:67–70.
48.
StockG, CallahanD, De GreyA. Debate: The ethics of life extension. Rejuvenation Res, 2007; 10:407–416.
49.
GooldI, SavulescuJ. In favour of freezing eggs for non-medical reasons. Bioethics, 2009; 23:47–58.
50.
SteinerAZ, PaulsonRJ. Parenting Issues Among Women of Advanced Reproductive Age: Does Age Really Matter?Fertil Steril, 2006; 85,Suppl 2:S8.
51.
SavulescuJ, GooldI. Freezing eggs for lifestyle reasons. Am J Bioeth, 2008; 8:32–35.
52.
KassLR. L'chaim and its limits. Why not immortality? First Things, 2001; 113:17–24.
53.
HarrisJ. Intimations of immortality: the ethics and justice of life extending therapies. Current Legal Problems, 2002; 55:65–95.
54.
JuengstETet al.Biogerontology, “Anti-aging Medicine”, and the challenges of human enhancement. Hastings Center Report, 2003; 33:21–30.
55.
The President's Council on Bioethics. Ageless bodies, in: Beyond therapy. Biotechnology and the pursuit of happiness. Washington: Dana Press, 2003; 179–229.
56.
GemsD. Is more life always better? The new biology of aging and the meaning of life. Hastings Center Report, 2003; 33:31–39.
57.
de GreyADNJ. Life-extension biomedicine: An unusual gathering. Rejuventation Res, 2006; 9:374–377.
58.
PijnenburgM, LegetC. Who wants to live forever? Three arguments against extending the human lifespan. Journal of Medical Ethics, 2007; 33:585–587.
59.
StockG, CallahanD, de GreyADNJ. Debate: The ethics of life extension. Rejuventation Res, 2007; 10:407–416.
60.
LaddJ. The internal morality of medicine: An essential dimension of the physician-patient relationship. ShelpEE. The clinical encounter: Dordrecht: Reidel, 1983; 209–231.
61.
ConradP. The shifting engines of medicalization. J Health Soc Behav, 2005; 46:3–14ConradP. The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore: Johns Hopkins University Press, 2007.
62.
KaufmanSR, ShimJK, RussAJ. Revisiting the biomedicalization of aging: Clinical trends and ethical challenges. Gerontologist, 2004; 44:731–738MykytynCE. Medicalizing the optimal: Anti-aging medicine and the quandary of intervention. J Aging Studies, 2008; 22:313–321.
63.
KassLR. The end of medicine and the pursuit of health. Toward a more natural science. The Free Press: New York, 1985; 157–186.
64.
PellegrinoED. Philosophy of medicine: Should it be teleologically or socially construed?Kennedy Inst Ethics J, 2001; 11:169–180.
65.
MillerFG, BrodyH, ChungKC. Cosmetic surgery and the internal morality of medicine. Cambr Q Healthcare Ethics 2000;9:353–364; Kettner M. The authority of desire in medicine. DüwellM, Rehmann-SutterC, MiethD. The contingent nature of life. Bioethics and limits of human existence: Springer, 2008; 97–108.
66.
ParensE. Enhancing human traits: ethical and social implications. Georgetown University Press: Washington, 1998.
67.
LenkC. Health and Enhancement. GimmlerA, LenkC, AumüllerG. Health and Quality of Life: Philosophical, Medical, and Cultural Aspects: Lit Verlag, Münster, 2002; 37–46.
68.
ParksJA. A closer look at reproductive technology and postmenopausal motherhood. Can Med Assoc J, 1996; 154:1189–1191.
69.
ElliotC. Pursued by happiness and beaten senseless. Prozac and the American dream. The Hastings Center Rep, 2000; 30:7–12.
70.
ParensE. The goodness of fragility: On the prospect of genetic technologies aimed at the enhancement of human capacities. Kennedy Inst Ethics J, 1995; 5:141–153.
71.
CallahanD. Aging and the life cycle: A moral norm?CallahanD, ter MeulenR, TopinkováE. A world growing old: The coming health care challenges. Georgetown University Press: Washington, 1995; 20–27PartridgeB, HallW. The search for Methuselah. Should we endeavour to increase the maximum human lifespan?EMBO Rep, 2007; 8:888–891.
72.
FootP. The Grammer of Goodness. VoorhoeveA. Conversations on Ethics. Oxford University Press: Oxford, 2009.
73.
BuchananA. Human nature and Enhancement. Bioethics, 2009; 23:141–150.
74.
HawkesK, O'ConnellJFO, Blurton JonesNG, AlvarezH, CharnovEL. Grandmothering, menopause, and the evolution of human life histories. Proc Natl Acad Sci, 1998; 95:1336–1339.
75.
CoadyCAJ. Playing God. SavulescuJ, BostromN. Human Enhancement. Oxford University Press: Oxford, 2009.
76.
BenagianoG. Pregnancy after the menopause: A challenge to Nature?Hum Reprod, 1993; 8:1344–1345.
